How Do These Two Top International ETFs Stack Up Against Each Other?

Vanguard Total International Stock ETF (VXUS) and iShares Core MSCI Total International Stock ETF (IXUS) offer nearly identical international exposure and trailing performance—1‑yr returns of 31.83% and 31.67% respectively—while differing on scale and breadth: VXUS has $133.1B AUM and ~8,602 holdings versus IXUS’s $54.4B and ~4,211 holdings. Expense ratios are 0.05% (VXUS) and 0.07% (IXUS), dividend yields ~2.96% vs 3.01%, and betas of 1.00 vs 0.76; sector weightings and top positions are similar, with financials, industrials and tech prominent. The practical decision drivers for allocators are VXUS’s broader diversification and quarterly payouts versus IXUS’s slightly higher yield and semiannual distributions, with both funds carrying similar historical risk/return profiles.

Analysis

Market structure: Vanguard (VXUS) is the clear winner for incremental passive international flows — $133B AUM and a 0.05% ER vs IXUS $54B and 0.07% — which suggests continued reallocation into VXUS for cost-conscious core allocations. Large-cap non‑US tech/semiconductor names (TSM, ASML, Samsung) are indirect beneficiaries because any incremental ETF inflows disproportionately land in the largest liquid constituents; conversely, active managers and niche EM small‑cap funds lose share. Dividend frequency (VXUS quarterly vs IXUS semi‑annual) and holding breadth (8,602 vs 4,211) shift retail/income investor preferences and liquidity footprint.

Risk assessment: Key tail risks are geopolitical shock (Taiwan‑China escalation) or tightened semiconductor export controls that could knock 10–30% off TSM/ASML and propagate to both ETFs given top‑weight concentration. Short‑term (days–weeks) is dominated by flows and FX swings (USD), medium (3–12 months) by earnings/capital spending in semis, long term by structural EM growth and index composition drift. Hidden dependency: VXUS’s broader microcap sleeve increases tracking‑error and liquidity risk during stress; tax/withholding differences can create after‑tax performance gaps in taxable accounts.

Trade implications: For core exposure, favor VXUS for new contributions (lower ER, deeper AUM); tactically overweight TSM (TSM) and ASML (ASML) for semiconductor secular upside (6–24 months). Implement downside insurance: limited‑cost put spreads on VXUS or notional hedges sized to cover 30–50% of international exposure for 3–6 months if volatility <20% and put premiums are <2.5% of notional. Consider relative trade long VXUS vs short SPY (beta‑neutral) for 3–12 months to capture international mean‑reversion if VXUS underperforms US by >6%.

Contrarian angles: Consensus understates the operational cost of VXUS’s microcaps — breadth can be a liability in a risk‑off repricing, not just diversification; investors blindly switching for 2 bps savings may incur higher implicit liquidity and tracking costs. Historical parallel: 2018 EM selloff showed broader indices with microcap exposure underperformed during liquidity stress by ~5–10% vs concentrated large‑cap international indexes. Unintended consequence: wholesale migrations into VXUS could concentrate retail ownership in illiquid names, amplifying future volatility and execution costs.

Key Decisions for Investors

• Shift new core international allocations to VXUS (Vanguard) rather than IXUS: size at 2–4% of portfolio, implement DCA over four weekly tranches to limit timing risk, hold 12–24 months; confirm average daily volume and bid/ask spread < $0.02 before execution.
• Establish tactical 1.5% position in TSM (TSM) and 1.5% in ASML (ASML) via three equal buys over 6 weeks; target 12–24 month hold, take‑profit at +40% and hard stop at -18% to capture semiconductor secular tailwinds concentrated inside international ETFs.
• Buy a 3‑month VXUS put spread to hedge 50% of international equity exposure (buy ATM put, sell ~10% lower strike) if the net premium is ≤2.5% of notional; execute immediately if VXUS implied volites are <20% and portfolio drawdown protection is required.
• Implement a relative value trade: go long VXUS and short SPY sized to be market beta‑neutral (target net beta ~0) representing 1–3% of portfolio capital, hold 3–12 months; reduce if VXUS outperforms SPY by >6% in any 3‑month window to lock gains.